Conviction demands deeper research than microcap confidence

Building Conviction the Hard Way with Kris Tuttle, Founder of IPO Candy and CIO of Blue Caterpillar

Small-cap investors face a tension between finding overlooked opportunities and avoiding theses built on incomplete evidence, especially when macro conditions can overwhelm company fundamentals.

3 key takeaways
  1. 1Conviction requires explicit thesis tests, ongoing execution checks, and the discipline to abandon ideas when industry evidence changes.
  2. 2Tuttle screens companies through financial, management, dilution, insider, awareness, and thematic criteria before committing research time.
  3. 3Small-cap analysis now demands both company-level depth and a working understanding of liquidity, rates, and end-market conditions.

Don't miss

Tuttle turns his BEA experience into a demanding standard for analysts: understand one company, its industry, economics, and financial model better than its executives.

The brief

Kris Tuttle draws on IBM AI work, institutional sales, and microcap investing to explain why overlooked companies require more than persuasive narratives.

His research workflow moves from unfiltered idea discovery to deeper analysis and portfolio monitoring, using AI to scale the process without replacing judgment.

Tuttle’s conviction framework is deliberately conditional: execution, industry evidence, dilution, management behavior, and risk-reward can all overturn a promising thesis.

At conferences, he uses a 31-criteria assessment and leaves room for unplanned presentations, where overlooked companies can challenge a carefully curated research list.

The episode’s clearest lesson comes from BEA: choose one company, master its business and economics, and build understanding deeper than surface-level confidence.

What was said on this episode

16 statements · 8 positive · 5 negative · 3 neutral

  1. Kris Tuttleon enterprise AI adoptionNeutral5:29

    Enterprise AI adoption depends on demonstrating return on investment.

    “enterprises are ultimately driven by ROI”

    Listen at 5:29

  2. Kris Tuttleon institutional investment decisionsNeutral6:31

    Institutions tend to buy investments that are compelling and easy to understand.

    “institutions buy things that are compelling, things with a story.”

    Listen at 6:31

  3. Kris Tuttleon small-cap equitiesPositive10:01

    Small-cap equities offer substantial opportunities for research-driven market edge.

    “The place where you can have tremendous edge if you like research is in small-cap equities.”

    Listen at 10:01

  4. Kris Tuttleon small-cap equitiesPositive10:41

    Small-cap markets contain companies that are unknown or misunderstood.

    “you can find companies and opportunities that are either completely unknown or quite misunderstood”

    Listen at 10:41

  5. Kris Tuttleon investment evaluation criteriaNeutral19:45

    Execution and results are key criteria for evaluating investments.

    “execution and results are one of the key things that we look at.”

    Listen at 19:45

  6. Kris Tuttleon small-cap company executionPositive20:08

    Small-cap companies should execute at Nvidia's standard.

    “You should execute like Nvidia”

    Listen at 20:08

  7. Kris Tuttleon repeatedly unsuccessful investment themesNegative21:15

    Repeatedly unsuccessful investment themes should generally be avoided.

    “we tend to avoid, well, we'll cross off whole areas because you'd have to either have insider information or be extraordinarily lucky to make money at those things.”

    Listen at 21:15

  8. Kris Tuttleon assembly, test, and packaging companiesPositive22:21

    Assembly, test, and packaging companies may be more attractive semiconductor investments than Nvidia or AMD.

    “all the assembly, test, and packaging companies, Aehr included, are looking like maybe way more interesting to play semiconductors than Nvidia and AMD”

    Listen at 22:21

  9. Kris Tuttleon early-stage wafer-level testing and assemblyNegative22:45

    Changed industry signals can invalidate an investment thesis despite company execution.

    “if those signals change, then even if the companies are executing, one last example of where we'd say maybe we were wrong”

    Listen at 22:45

  10. Kris Tuttleon biotech Phase 3 trial readoutsNegative23:42

    Biotech investors should not hold positions through Phase 3 trial results.

    “the first rule of biotech is you never own anything when they're going to announce results for a phase 3 trial.”

    Listen at 23:42

  11. Kris Tuttleon biotech companiesPositive24:15

    Biotech investors should buy before broad recognition and sell immediately after recognition.

    “you buy the company for the promise before the promise is appreciated by the investment community, and then you sell it immediately after that.”

    Listen at 24:15

  12. Kris Tuttleon biotech investingPositive25:24

    Generalist biotech investors should select opportunities with multiple confirming evidence sources.

    “you really need to pick your spots there and make sure you have, I would call multiple sources of confirming evidence”

    Listen at 25:24

  13. Kris Tuttleon Kalshi and Polymarket event contractsPositive26:38

    Betting against event outcomes on Kalshi and Polymarket would have produced strong returns.

    “if you had the tools and you just bet on the no outcome of everything on those platforms, you'd make a very nice return”

    Listen at 26:38

  14. Kris Tuttleon company management teamsNegative32:11

    Evidence that management lied on a recent call makes meeting them unattractive.

    “if I could tell they're lying in the conference call from the last quarter, maybe it's probably not worth my time to meet them.”

    Listen at 32:11

  15. Kris Tuttleon underperforming companiesPositive33:14

    Underperforming companies should generally have a new CEO.

    “if the company hasn't been performing, we kind of like to see a new CEO.”

    Listen at 33:14

  16. Kris Tuttleon small-cap stocksNegative38:19

    Stocks will not rise without companies improving investor-facing communication.

    “the whole reason we're doing this is we'd like, would like the stocks to go up at some point. So that's not gonna happen by magic.”

    Listen at 38:19

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Books & mentions

IPO Candy

A natural next step for exploring the research platform Tuttle references.

MicroCapClub

A related community for following small-company research and investor discussions.

Weekly email

State of the Pod, every Monday

The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.

Listen to the full episode and explore every guest, topic, and moment on PodLume.